Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.

Not Applicable

Completed

• Conditions: Candidiasis, Esophageal; HIV Infections

• Registration Number: NCT00002132
• Lead Sponsor: Janssen Pharmaceuticals

Brief Summary

To evaluate the safety and efficacy of itraconazole oral solution versus fluconazole tablets for the treatment of esophageal candidiasis in immunocompromised patients.

Detailed Description

Not available

Study Timeline

• Status Verified: 1996-04
• Study First Submitted: 1999-11-02
• Study First Submitted QC: 2001-08-30
• Study First Posted: 2001-08-31
• Last Update Submitted: 2005-06-23
• Last Update Posted: 2005-06-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (18)

Dr Eskild A Petersen; 🇺🇸 Tucson, Arizona, United States

Los Angeles County - USC Med Ctr; 🇺🇸 Los Angeles, California, United States

UCSD Med Ctr; 🇺🇸 San Diego, California, United States

George Washington Univ Med Ctr; 🇺🇸 Washington, District of Columbia, United States

Emory Univ School of Medicine; 🇺🇸 Atlanta, Georgia, United States

Rush Presbyterian - Saint Luke's Med Ctr; 🇺🇸 Chicago, Illinois, United States

Johns Hopkins Univ School of Medicine; 🇺🇸 Baltimore, Maryland, United States

Wayne State Univ / Harper Hosp; 🇺🇸 Detroit, Michigan, United States

Univ of Missouri at Kansas City School of Medicine; 🇺🇸 Kansas City, Missouri, United States

Infectious Diseases Association / Research Med Ctr; 🇺🇸 Kansas City, Missouri, United States

Scroll for more (8 remaining)